Major Breakthrough Lets People With Irreversible Blindness See
The trial is being hailed as a “paradigm shift.”

University of Pittsburgh
A new eye implant has improved the vision of 81 percent of trial participants suffering from the most common cause of irreversable blindness among the elderly. José-Alain Sahel. study author and chair of ophthalmology department at the University of Pittsburgh School of Medicine, said, “It’s the first time that any attempt at vision restoration has achieved such results in a large number of patients. More than 80 per cent of the patients were able to read letters and words, and some of them are reading pages in a book.” The study was carried out on people with geographic atrophy, a subtype of advanced age-related macular degeneration. AMD harms central vision, which allows people do things like drive and read. The Financial Times reported participants registered “clinically meaningful improvements in their vision.” The device mounts a camera on a pair of bespoke glasses, which then projects onto an implant in patients’ retinas. The findings of the experiment were published in the New England Journal of Medicine. The paper’s lead author, Frank Holz, hailed the signifigance of the breakthrough. “This study confirms that, for the first time, we can restore functional central vision in patients blinded by geographic atrophy,” he said. “The implant represents a paradigm shift in treating late-stage age-related macular degeneration.”
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.